Is Constellation Brands' Focus on Core Brands the Key to Success?

miércoles, 11 de marzo de 2026, 1:57 pm ET3 min de lectura
STZ--

Constellation Brands, Inc. STZ remains a leading player across the beer, wine and spirits space, supported by its strong focus on premiumization, brand strength and disciplined portfolio management. The company boasts a portfolio of consumer-driven, high-quality brands, including Modelo Especial, Corona Extra, Pacifico, Robert Mondavi Winery, High West and more. With these well-established labels, Constellation BrandsSTZ-- is well-positioned to cater to evolving consumer preferences and capture growth opportunities in the beverage market.

The company has increasingly centered its strategy on core, high-growth premium brands across beer, wine and spirits. This focus is designed to strengthen market share, improve margins and drive sustainable long-term growth. STZ’s brand-building efforts, further complemented by momentum in the beer business, tapping premiumization, innovations and solid cost savings, remain encouraging.

Key growth drivers included the company's high-end Power Brands, such as The Prisoner Brand Family, Kim Crawford and Meiomi. The beer segment has also been experiencing gains from premiumization, driven by growth in traditional beer and flavored categories, including seltzers, flavored beer, RTD spirits and flavored malt beverages. Constellation Brands is on track with its plans to invest in capacity expansion in Mexico.

Constellation Brands emphasizes a portfolio aimed at high-margin, growth categories across the beverage alcohol industry by leveraging direct-to-consumer platforms and enhanced global presence. Modelo, Corona and Pacifico are the backbones, reinforcing STZ’s leadership position in the broader U.S. beer space. The company is investing in its Power Brands through innovation and capitalizing on priority consumer trends with successful product introductions.

At its core, Constellation Brands’ emphasis on core premium brands allows it to capitalize on premiumization trends, improve profitability and reinforce its leadership in the beverage alcohol industry. If consumer demand for premium beverages remains strong, this strategy could be a key driver of the company’s success.

STZ’s Price Performance, Valuation & Estimates

Shares of Constellation Brands have gained 7.6% in the past six months compared with the industry’s growth of 9.7%.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, STZSTZ-- trades at a forward price-to-earnings ratio of 12.09X compared with the industry’s average of 15.17X.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for STZ’s fiscal 2026 earnings implies a year-over-year decline of 15.5%, while that for fiscal 2027 indicates growth of 6.5%. The company’s EPS estimates for fiscal 2026 and fiscal 2027 have been stable in the past 30 days.

Zacks Investment Research
Image Source: Zacks Investment Research

Constellation Brands stock currently carries a Zacks Rank #3 (Hold).

Key Consumer Staple Picks

Freshpet, Inc. FRPT, which is a pet food company, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 9.8% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.

B&G Foods, Inc. BGS boasts a diversified portfolio of brands, including B&G, B&M, Cream of Wheat, Las Palmas, and others, and currently carries a Zacks Rank of 2.

The Zacks Consensus Estimate for B&G Foods’ current financial-year earnings is expected to rise 5.9% from the year-ago reported figure. BGS delivered a trailing four-quarter negative earnings surprise of 19.5%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.

The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number.

Radical New Technology Could Hand Investors Huge Gains

Quantum Computing is the next technological revolution, and it could be even more advanced than AI.

While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.

Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.

Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.

See Top Quantum Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report



Freshpet, Inc. (FRPT): Free Stock Analysis Report

Constellation Brands Inc (STZ): Free Stock Analysis Report

B&G Foods, Inc. (BGS): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios